Kolexia
Goujon Morgan Oncologie médicale
Goujon Morgan
Oncologie médicale
Hôpital Jean-Minjoz
Besançon, France
50 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Néphrocarcinome Tumeurs du rein Carcinome épidermoïde Fatigue Tumeurs de la prostate Tumeurs du sein Tumeurs du pénis Troubles de l'endormissement et du maintien du sommeil

Collaborateurs

Voir plus
Gassian Noémie
Gassian Noémie
Centre Hospitalier de Auxerre, Auxerre, France
Klajer Elodie
Klajer Elodie
Hôpital Jean-Minjoz, Besançon, France
Bolognini Clément
Bolognini Clément
Hôpital Jean-Minjoz, Besançon, France
Thiery-Vuillemin Antoine
Thiery-Vuillemin Antoine
Le Mittan Annexe Du Hnfc, Montbéliard, France

Industries

Voir plus
A+A
78 collaboration(s)
Dernière en 2023
Parexel
36 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
31 collaboration(s)
Dernière en 2023
Ipsen
3 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Gastrointestinal metastases in renal cell carcinoma: A retrospective multicenter GETUG (Groupe d'Étude des Tumeurs Uro-Génitales) study.
European journal of cancer (Oxford, England : 1990)   15 janvier 2024
A randomized trial to evaluate the effects of a supervised exercise program on insomnia in patients with non-metastatic breast cancer undergoing chemotherapy: design of the FATSOMCAN study.
BMC cancer   17 mai 2023
PULSE: Activity and Tolerability of Maintenance Avelumab Immunotherapy After First Line Polychemotherapy Including Platinum in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma
Essai Clinique (Pfizer)   20 avril 2023
Metastatic renal cell cancer and first-line combinations: for which patients? (focus on tolerance and health-related quality of life).
Bulletin du cancer   29 juin 2022
FATSOMCAN: Effects of a Supervised Exercise on Sleep in Patients With Non Metastatic Breast Cancer During Chemotherapy
Essai Clinique (CHU Besançon)   31 mai 2022
Evaluation of drug-drug interactions among patients with metastatic prostate cancer in routine care.
2022 ASCO Genitourinary Cancers Symposium   16 février 2022
Association of health-related quality of life (HRQOL) variations with biological biomarkers for patients with metastatic castrate-resistant prostate cancer (MCRPC) treated by abiraterone/prednisone combination or prednisone.
2021 Genitourinary Cancers Symposium   02 mars 2021
Activity and tolerability of maintenance avelumab immunotherapy after first line polychemotherapy including platinum in patients with locally advanced or metastatic squamous cell penile carcinoma: PULSE.
Bulletin du cancer   16 juillet 2020
Targeted and immune therapies among patients with metastatic renal carcinoma undergoing hemodialysis: A systemic review.
Seminars in oncology   26 mai 2020
Radiotherapy of oligometastases: Sequences and interactions with systemic therapies, example of kidney cancer.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   04 octobre 2019